In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser. UPS Solves "Hot" Issue in Pharma with New Cold Chain Container - UPS Pressroom
Browse By Topic
Browse By Date
Browse By Content Type
Browse By Language
Browse By Country

World of News

Find news where it happens Explore Now»

Events

UPS Solves "Hot" Issue in Pharma with New Cold Chain Container

Atlanta, September 28, 2011

PharmaPort™ 360 Delivers Unmatched Product Protection

UPS (NYSE: UPS) today announced it will offer an innovative air freight container for healthcare products, providing an unparalleled level of shipment monitoring and product protection for temperature-sensitive pharmaceuticals, vaccines and biologics.

Only available through UPS, the PharmaPort 360 addresses a key industry issue of safeguarding healthcare shipments in the supply chain by enabling near real-time monitoring and maintaining product temperatures in extreme outside conditions. 

"Amid the tremendous surge of temperature-sensitive therapies coming to market, it's critical to have the most reliable solutions in place to help ensure the safe supply of healthcare products while also driving cost and operational efficiencies for healthcare manufacturers," said Mark Davis, product manager, UPS Healthcare Logistics. "The stakes are high when there's a patient at the end of the supply chain, and UPS strongly believes that the PharmaPort 360 will ensure better protection of potentially life-saving therapies."

Manufactured by Cool Containers, LLC for UPS, the PharmaPort 360 is designed with input from both the life sciences and transportation industries. The unit is fully validated and tested and exceeds rigorous healthcare industry standards for temperature-sensitive compliance during transportation.

The PharmaPort 360 container maintains strict temperatures by utilizing both heating and cooling storage technology, allowing it to tolerate a significantly wider range of extreme ambient temperature changes. The container more effectively maintains temperatures critical for protecting medicines that need to stay within the required 2-8°C to prevent spoilage. The PharmaPort 360 also sustains its protective temperature range for more than 100 hours, which is an important factor as more supply chains extend globally and healthcare products need to travel farther to reach markets.

The container's temperature control and monitoring systems are powered by an AC rechargeable battery. The unit's technology replaces the need for dry ice, thus eliminating the associated handling fees and hazardous materials charges. Also, the PharmaPort 360 will hold critical 2-8°C temperatures 38 percent longer than current dry ice container solutions.

Unlike other containers on the market, the PharmaPort 360 has built-in sensors that not only monitor shipment condition and GPS location but transmit this data to UPS's global control towers via GSM, a standard global cellular network. Agents proactively monitor the container for select "heartbeats" such as internal and external temperatures, near real-time location and battery life. When alerts are triggered indicating a potential risk, UPS agents can intervene with pre-established contingency plans to rescue a shipment in distress and prevent product loss.

"Product losses from temperature excursions and mounting scrutiny from regulatory authorities are pressuring healthcare companies to strengthen supply chain compliance and gain more control through shipment data," Davis added. "Having the information to prove that the integrity of a vaccine or human tissue has been preserved in-transit, for example, is almost as critical as the contents of the package."

The PharmaPort 360's unique design also allows for more flexibility for flight options. While in transit mode, the container neither consumes energy nor emits external heat, vapor or gasses, allowing the unit to fly in both upper and lower deck aircraft positions. This offers more routing options, especially in constrained transportation lanes. The Federal Aviation Authority also has approved the PharmaPort 360 to fly on both narrow-body and wide-body aircraft, allowing for a high degree of flexibility in flight selections and opening access to markets globally.

As a part of UPS's latest temperature-sensitive capabilities, the PharmaPort 360 is available exclusively through UPS Temperature True, a service designed to safeguard cold-chain shipments. The service includes priority routing of shipments, temperature-sensitive handling and storage, around-the-clock proactive monitoring and intervention services in the event of unexpected delays.

For more information on the PharmaPort 360 visit ups.com/pp360 or for other UPS healthcare information, visit: ups.com/healthcare.


About UPS
UPS (NYSE: UPS) is a global leader in logistics, offering a broad range of solutions including the transportation of packages and freight; the facilitation of international trade, and the deployment of advanced technology to more efficiently manage the world of business. Headquartered in Atlanta, UPS serves more than 220 countries and territories worldwide. The company can be found on the Web at UPS.com and its corporate blog can be found at blog.ups.com. To get UPS news direct, visit pressroom.ups.com/RSS.

To ask about this press release, contact:

UPS Public Relations

404-828-8821

print Send Page
share

Send this Press Release:


(Use a comma to separate addresses)

(500 characters remaining)

Cancel